Veeva Systems Inc. (VEEV)
NYSE: VEEV · Real-Time Price · USD
232.07
-1.62 (-0.69%)
May 1, 2025, 4:00 PM EDT - Market closed
Veeva Systems Revenue
In the fiscal year ending January 31, 2025, Veeva Systems had annual revenue of $2.75B with 16.20% growth. Veeva Systems had revenue of $720.89M in the quarter ending January 31, 2025, with 14.31% growth.
Revenue (ttm)
$2.75B
Revenue Growth
+16.20%
P/S Ratio
13.68
Revenue / Employee
$376,714
Employees
7,291
Market Cap
37.76B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jan 31, 2025 | 2.75B | 382.95M | 16.20% |
Jan 31, 2024 | 2.36B | 208.61M | 9.68% |
Jan 31, 2023 | 2.16B | 304.28M | 16.44% |
Jan 31, 2022 | 1.85B | 385.71M | 26.33% |
Jan 31, 2021 | 1.47B | 360.99M | 32.70% |
Jan 31, 2020 | Pro | Pro | Pro |
Jan 31, 2019 | Pro | Pro | Pro |
Jan 31, 2018 | Pro | Pro | Pro |
Jan 31, 2017 | Pro | Pro | Pro |
Jan 31, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
VEEV News
- 3 days ago - Announcing Veeva AI - PRNewsWire
- 15 days ago - Flatiron Health Joins Veeva's Product Partner Program to Accelerate Oncology Clinical Research - Business Wire
- 4 weeks ago - Veeva Announces Research Site Clinical Trial Management System - PRNewsWire
- 6 weeks ago - Indero Marks 40th Study Live with Veeva RTSM - PRNewsWire
- 6 weeks ago - Veeva Systems: Staying Buy Rated As VEEV Is Executing Well - Seeking Alpha
- 7 weeks ago - Veeva Shares Advance on Revenue, AI Growth - FXEmpire
- 7 weeks ago - Boehringer Ingelheim Partners with Veeva to Launch 'One Medicine Platform' - PRNewsWire
- 7 weeks ago - Veeva Systems: Solid Q4 With Margin Expansion - Seeking Alpha